Day One Biopharmaceuticals Non-Current Deferred Revenue (Quarterly) Analysis

Day One Biopharmaceuticals, Inc. (DAWN)

10.76 -0.57 (-5.03%) USD | NASDAQ | Jan 13, 13:45

View Non-Current Deferred Revenue (Quarterly) for DAWN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Mersana Therapeutics, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Electromed, Inc.	--
InfuSystem Holdings, Inc.	--
Xtant Medical Holdings, Inc.	--